IT1398977B1 - ANTI-PANT AGENT SPECIFIC FOR CEREBRAL CANCERS WITH RECQ1 SUPPRESSION MECHANISM - Google Patents
ANTI-PANT AGENT SPECIFIC FOR CEREBRAL CANCERS WITH RECQ1 SUPPRESSION MECHANISMInfo
- Publication number
- IT1398977B1 IT1398977B1 ITRM2009A000328A ITRM20090328A IT1398977B1 IT 1398977 B1 IT1398977 B1 IT 1398977B1 IT RM2009A000328 A ITRM2009A000328 A IT RM2009A000328A IT RM20090328 A ITRM20090328 A IT RM20090328A IT 1398977 B1 IT1398977 B1 IT 1398977B1
- Authority
- IT
- Italy
- Prior art keywords
- recq1
- pant
- suppression mechanism
- agent specific
- cerebral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
- C12Y306/04—Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; involved in cellular and subcellular movement (3.6.4)
- C12Y306/04012—DNA helicase (3.6.4.12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2009A000328A IT1398977B1 (en) | 2009-06-25 | 2009-06-25 | ANTI-PANT AGENT SPECIFIC FOR CEREBRAL CANCERS WITH RECQ1 SUPPRESSION MECHANISM |
PCT/IB2010/052763 WO2010150159A1 (en) | 2009-06-25 | 2010-06-18 | Anticancer agent specific for brain tumors with mechanism of recq1 suppression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2009A000328A IT1398977B1 (en) | 2009-06-25 | 2009-06-25 | ANTI-PANT AGENT SPECIFIC FOR CEREBRAL CANCERS WITH RECQ1 SUPPRESSION MECHANISM |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20090328A1 ITRM20090328A1 (en) | 2010-12-26 |
IT1398977B1 true IT1398977B1 (en) | 2013-03-28 |
Family
ID=41818364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM2009A000328A IT1398977B1 (en) | 2009-06-25 | 2009-06-25 | ANTI-PANT AGENT SPECIFIC FOR CEREBRAL CANCERS WITH RECQ1 SUPPRESSION MECHANISM |
Country Status (2)
Country | Link |
---|---|
IT (1) | IT1398977B1 (en) |
WO (1) | WO2010150159A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2844398T3 (en) * | 2015-07-31 | 2021-07-22 | Genecare Res Institute Co Ltd | Modified siRNA and pharmaceutical composition comprising the same |
KR20210121092A (en) * | 2019-01-29 | 2021-10-07 | 유니버시티 오브 워싱턴 | Gene editing methods |
WO2021132648A1 (en) * | 2019-12-27 | 2021-07-01 | ルクサナバイオテク株式会社 | Antisense oligonucleotide for inhibiting recql expression, and application for same |
WO2024004779A1 (en) * | 2022-06-30 | 2024-01-04 | 株式会社ジーンケア研究所 | Sirna targeting recql1 helicase gene |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001077350A2 (en) | 2000-04-07 | 2001-10-18 | Large Scale Biology Corporation | Compositions and methods for inhibiting gene expression |
ITRM20030196A1 (en) | 2003-04-24 | 2004-10-25 | Sigma Tau Ind Farmaceuti | USE OF REAGENTS FOR THE PREPARATION OF A DRUG |
WO2004100990A1 (en) * | 2003-05-19 | 2004-11-25 | Genecare Research Institute Co., Ltd. | Apoptosis inducer for cancer cell |
WO2005097207A2 (en) | 2004-03-26 | 2005-10-20 | Curis, Inc. | Rna interference modulators of hedgehog signaling and uses thereof |
DE602005015994D1 (en) | 2004-09-29 | 2009-09-24 | Childrens Memorial Hospital | siRNA-mediated gene silencing of alpha-synuclein |
JP4809240B2 (en) * | 2004-11-19 | 2011-11-09 | 株式会社ジーンケア研究所 | Cancer cell-specific cell growth inhibitor |
-
2009
- 2009-06-25 IT ITRM2009A000328A patent/IT1398977B1/en active
-
2010
- 2010-06-18 WO PCT/IB2010/052763 patent/WO2010150159A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2010150159A1 (en) | 2010-12-29 |
ITRM20090328A1 (en) | 2010-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2018001I1 (en) | Harmonized therapy for COPD | |
EP2266043A4 (en) | Cache optimzation | |
EP2143051A4 (en) | In-memory caching of shared customizable multi-tenant data | |
BRPI1009222A2 (en) | door for wash | |
BRPI1015921A2 (en) | gpr119 agonists | |
BR112012005247A2 (en) | antifitoviral agent | |
BRPI0924653A2 (en) | stable iron oligosaccharide compound | |
BR112013024082A2 (en) | fluorescent whitening agent compositions | |
BRPI1015435A2 (en) | Extruded particles | |
HK1177694A1 (en) | Calcipotriol monohydrate nanocrystals | |
GB0918722D0 (en) | Anti cancer agent | |
IT1398977B1 (en) | ANTI-PANT AGENT SPECIFIC FOR CEREBRAL CANCERS WITH RECQ1 SUPPRESSION MECHANISM | |
BRPI0923835A2 (en) | Foaming agent | |
BR112013004785A2 (en) | cytoprotective agent | |
ITRE20110041A1 (en) | SANITARY AGENT | |
IT1395215B1 (en) | ENGAGEMENT MECHANISM WITH BRAKE | |
BRPI1013212A2 (en) | dust suppressing agent | |
BR112012003115A2 (en) | after clarification agent | |
IT1401482B1 (en) | DOOR STOP | |
GB0813213D0 (en) | Anti cancer agent | |
ITPS20080003U1 (en) | JAMBOARD STRUCTURE FOR DOOR | |
BRPI0822940A2 (en) | anti-splash agent | |
GB201020776D0 (en) | Voltage-gated sodium channel agent | |
UA18899S (en) | TRANSVERSE PROFILE FOR SLIDING DOOR PADS | |
UA18897S (en) | TRANSVERSE PROFILE FOR SLIDING DOOR PADS |